Susan M Landau, Theresa M Harrison, Suzanne L Baker, Martin S Boswell, JiaQie Lee, Jacinda Taggett, Tyler J Ward, Trevor Chadwick, Alice Murphy, Charles DeCarli, Christopher G Schwarz, Prashanthi Vemuri, Clifford R Jack, Robert A Koeppe, William J Jagust
{"title":"阿尔茨海默病神经影像学计划中的正电子发射断层扫描协调:多部位淀粉样蛋白和 tau 定量的可扩展严格方法。","authors":"Susan M Landau, Theresa M Harrison, Suzanne L Baker, Martin S Boswell, JiaQie Lee, Jacinda Taggett, Tyler J Ward, Trevor Chadwick, Alice Murphy, Charles DeCarli, Christopher G Schwarz, Prashanthi Vemuri, Clifford R Jack, Robert A Koeppe, William J Jagust","doi":"10.1002/alz.14378","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>A key goal of the Alzheimer's Disease NeuroImaging Initiative (ADNI) positron emission tomography (PET) Core is to harmonize quantification of β-amyloid (Aβ) and tau PET image data across multiple scanners and tracers.</p><p><strong>Methods: </strong>We developed an analysis pipeline (Berkeley PET Imaging Pipeline, B-PIP) for ADNI Aβ and tau PET images and applied it to PET data from other multisite studies. Steps include image pre-processing, refacing, magnetic resonance imaging (MRI)/PET co-registration, visual quality control (QC), quantification of tracer uptake, and standardization of Aβ and tau standardized uptake value ratios (SUVrs) across tracers.</p><p><strong>Results: </strong>Measurements from 10,105 cross-sectional and longitudinal Aβ and tau PET scans acquired in several studies between 2010 and 2024 can be processed, harmonized, and directly merged across tracers and cohorts.</p><p><strong>Discussion: </strong>The B-PIP developed in ADNI is a scalable image harmonization approach used in several observational studies and clinical trials that facilitates rigorous Aβ and tau PET quantification and data sharing.</p><p><strong>Highlights: </strong>Quantitative results from ADNI Aβ and tau PET data are generated using a rigorous, scalable image processing pipeline This pipeline has been applied to PET data from several other large, multisite studies and trials Quantitative outcomes are harmonizable across studies and are shared with the scientific community.</p>","PeriodicalId":7471,"journal":{"name":"Alzheimer's & Dementia","volume":" ","pages":""},"PeriodicalIF":13.0000,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Positron emission tomography harmonization in the Alzheimer's Disease Neuroimaging Initiative: A scalable and rigorous approach to multisite amyloid and tau quantification.\",\"authors\":\"Susan M Landau, Theresa M Harrison, Suzanne L Baker, Martin S Boswell, JiaQie Lee, Jacinda Taggett, Tyler J Ward, Trevor Chadwick, Alice Murphy, Charles DeCarli, Christopher G Schwarz, Prashanthi Vemuri, Clifford R Jack, Robert A Koeppe, William J Jagust\",\"doi\":\"10.1002/alz.14378\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>A key goal of the Alzheimer's Disease NeuroImaging Initiative (ADNI) positron emission tomography (PET) Core is to harmonize quantification of β-amyloid (Aβ) and tau PET image data across multiple scanners and tracers.</p><p><strong>Methods: </strong>We developed an analysis pipeline (Berkeley PET Imaging Pipeline, B-PIP) for ADNI Aβ and tau PET images and applied it to PET data from other multisite studies. Steps include image pre-processing, refacing, magnetic resonance imaging (MRI)/PET co-registration, visual quality control (QC), quantification of tracer uptake, and standardization of Aβ and tau standardized uptake value ratios (SUVrs) across tracers.</p><p><strong>Results: </strong>Measurements from 10,105 cross-sectional and longitudinal Aβ and tau PET scans acquired in several studies between 2010 and 2024 can be processed, harmonized, and directly merged across tracers and cohorts.</p><p><strong>Discussion: </strong>The B-PIP developed in ADNI is a scalable image harmonization approach used in several observational studies and clinical trials that facilitates rigorous Aβ and tau PET quantification and data sharing.</p><p><strong>Highlights: </strong>Quantitative results from ADNI Aβ and tau PET data are generated using a rigorous, scalable image processing pipeline This pipeline has been applied to PET data from several other large, multisite studies and trials Quantitative outcomes are harmonizable across studies and are shared with the scientific community.</p>\",\"PeriodicalId\":7471,\"journal\":{\"name\":\"Alzheimer's & Dementia\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":13.0000,\"publicationDate\":\"2024-11-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Alzheimer's & Dementia\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1002/alz.14378\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alzheimer's & Dementia","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/alz.14378","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
摘要
导言:阿尔茨海默病神经成像计划(ADNI)正电子发射断层扫描(PET)核心的一个关键目标是统一多个扫描仪和示踪剂的β淀粉样蛋白(Aβ)和tau PET图像数据的量化:我们为ADNI Aβ和tau PET图像开发了一个分析管道(Berkeley PET Imaging Pipeline, B-PIP),并将其应用于其他多站点研究的PET数据。步骤包括图像预处理、重绘、磁共振成像(MRI)/PET联合注册、视觉质量控制(QC)、示踪剂摄取量化以及不同示踪剂的Aβ和tau标准化摄取值比(SUVrs)标准化:2010年至2024年期间多项研究获得的10105个横断面和纵向Aβ和tau正电子发射计算机断层扫描数据可以进行处理、统一,并在不同示踪剂和队列间直接合并:在ADNI中开发的B-PIP是一种可扩展的图像协调方法,用于多项观察性研究和临床试验,有助于严格的Aβ和tau PET量化和数据共享:ADNI Aβ和tau正电子发射计算机断层显像数据的定量结果是通过一个严格的、可扩展的图像处理管道生成的,该管道已应用于其他几项大型多站点研究和试验的正电子发射计算机断层显像数据。
Positron emission tomography harmonization in the Alzheimer's Disease Neuroimaging Initiative: A scalable and rigorous approach to multisite amyloid and tau quantification.
Introduction: A key goal of the Alzheimer's Disease NeuroImaging Initiative (ADNI) positron emission tomography (PET) Core is to harmonize quantification of β-amyloid (Aβ) and tau PET image data across multiple scanners and tracers.
Methods: We developed an analysis pipeline (Berkeley PET Imaging Pipeline, B-PIP) for ADNI Aβ and tau PET images and applied it to PET data from other multisite studies. Steps include image pre-processing, refacing, magnetic resonance imaging (MRI)/PET co-registration, visual quality control (QC), quantification of tracer uptake, and standardization of Aβ and tau standardized uptake value ratios (SUVrs) across tracers.
Results: Measurements from 10,105 cross-sectional and longitudinal Aβ and tau PET scans acquired in several studies between 2010 and 2024 can be processed, harmonized, and directly merged across tracers and cohorts.
Discussion: The B-PIP developed in ADNI is a scalable image harmonization approach used in several observational studies and clinical trials that facilitates rigorous Aβ and tau PET quantification and data sharing.
Highlights: Quantitative results from ADNI Aβ and tau PET data are generated using a rigorous, scalable image processing pipeline This pipeline has been applied to PET data from several other large, multisite studies and trials Quantitative outcomes are harmonizable across studies and are shared with the scientific community.
期刊介绍:
Alzheimer's & Dementia is a peer-reviewed journal that aims to bridge knowledge gaps in dementia research by covering the entire spectrum, from basic science to clinical trials to social and behavioral investigations. It provides a platform for rapid communication of new findings and ideas, optimal translation of research into practical applications, increasing knowledge across diverse disciplines for early detection, diagnosis, and intervention, and identifying promising new research directions. In July 2008, Alzheimer's & Dementia was accepted for indexing by MEDLINE, recognizing its scientific merit and contribution to Alzheimer's research.